Global Projects Information

Get latest news on International Projects. Upcoming Global Project News & New Project Information world wise. Search International & Global Projects for Infrastructure work, Power Projects, Energy Sector Oil & Gas Projects, Projects from Government sector, Railway, Water supply & sanitation work across the world. Search latest Global Projects News from Bid Detail.

1.

Ministère de la Santé Publique et de la Population

Strengthening Primary Health Care and Surveillance

  • 70 Million
  • Haiti
view notice less notice
Strengthening Primary Health Care and Surveillance
Company Name Ministère de la Santé Publique et de la Population
Funded By 106
Country Haiti , Caribbean
Project Value 70 Million
Project Detail

Objectives of Strengthening Primary Health Care and Surveillance Project for Haiti are to increase utilization of primary health care services in selected geographical areas, and strengthen surveillance capacity especially for cholera. The project has 4 components. (1) Strengthening primary health care service delivery component will finance activities to strengthen Primary Health Care (PHC) service delivery via PHC referral networks, with each network consisting of: (i) a community referral hospital, health centers and dispensaries operating at different levels within the network; and (ii) Community Health Workers at the community level. (2) Strengthening surveillance and control for infectious diseases component will help maintain the Ministry of Public Health and Population (MSPP’s) effective nationwide surveillance and response capacity in the fight against cholera achieved under the ongoing Improving Maternal and Child Health through Integrated Social Services (PASMISSI), while integrating cholera surveillance and response tools into the general surveillance and response systems. This component will continue to ensure the financing of critical surveillance and control activities for cholera and will expand to cover other infectious diseases, including two vaccine-preventable diseases – diphtheria and measles – and maternal deaths (all of which are part of the list of mandatory notifiable diseases), complementing the support of the Centers for Disease Control and Prevention (CDC) for MSPP’s surveillance capacity. (3) Supporting project management and implementation support component will finance activities to strengthen the capacity of the central MSPP units and Departmental health authorities in the coordination, implementation management and supervision of the Project (including fiduciary aspects and monitoring and evaluation, safeguards and reporting of Projec Read Less»

Sector Administration & Marketing

Contact Details

Company Name Ministère de la Santé Publique et de la Population
Address Andrew Sunil Rajkumar
Web Site http://projects.worldbank.org/P167512?lang=en

2.

INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

One size fits all unique drug to eradicate multiple viral species simultaneously from the central nervous system of co-infected individuals

  • 4 Million
  • Portugal
view notice less notice
One size fits all unique drug to eradicate multiple viral species simultaneously from the central nervous system of co-infected individuals
Company Name INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES
Funded By 38
Country Portugal , Western Europe
Project Value 4 Million
Project Detail

Viruses that infect the brain and other parts of the central nervous system are a worldwide threat of terrible dimensions. Viruses such as Zika, Dengue, Chikungunya, HIV or measles, for instance, are responsible for thousands of victims severely impaired at neurological level each year in the world. The most recent large scale threat in this domain was a Zika virus outbreak in South America. Zika virus, like Dengue virus or Chikungunya virus, is spread mainly by mosquitos of the genus Aedes. While Dengue and Chikungunya viruses, as many others, might causes diseases with severe neurological disorders, Zika virus is much more dreadful in this regard. When a pregnant woman is infected, the virus is able to translocate the blood-placental barrier and then the developing blood-brain barrier of the foetus, causing microcephaly and serious neurological disorders to newly born babies. Although co-infections with Aedes-borne viruses, such as the above mentioned Zika, Dengue and Chikungunya viruses, are likely because several viral species coexist in the same vector, the classical drug development strategies completely overlook this striking reality. Moreover, additional co-infections with HIV and measles virus, using other routes of infection, are also possible. A drug able to target a very large spectrum of viral species is urgently needed. Importantly, this drug must be able to traverse the blood-brain barrier and reach the viruses accumulated in the brain. NOVIRUSES2BRAIN is a project that aims at finding and selecting drug leads that are both efficacious and able to translocate the blood-placental and blood-brain barriers so that Zika, Dengue, Chikungunya and other viruses can be targeted across barriers, including during pregnancy. The project gathers the expertise of medicinal chemists, biochemists, drug development specialists and virologists to create drug leads able to clear all viral species from brain simultaneously.

Sector Administration & Marketing

Contact Details

Company Name INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES
Address Avenida Prof Egas Moniz 1649 028 Lisboa
Web Site https://cordis.europa.eu/project/rcn/220067/factsheet/en

3.

Global Alliance for Vaccines and Immunization

UK investment in Gavi, the Vaccine Alliance (2016-2020) - Gavi immunises children against vaccine preventable diseases including measles, rubella, cervical cancer (via the human papilloma virus vaccine) and certain types of pneumonia and diarrhoea.

  • 1,000 Billion
  • United States
view notice less notice
UK investment in Gavi, the Vaccine Alliance (2016-2020) - Gavi immunises children against vaccine preventable diseases including measles, rubella, cervical cancer (via the human papilloma virus vaccine) and certain types of pneumonia and diarrhoea.
Company Name Global Alliance for Vaccines and Immunization
Funded By UKAid Department for International Development
Country United States , Northern America
Project Value 1,000 Billion
Project Detail

Gavi currently works in 73 countries to save children’s lives by increasing equitable use of vaccines in the world’s poorest countries (the number will reduce as countries graduate from Gavi support). Gavi immunises children against vaccine preventable diseases including measles, rubella, cervical cancer (via the human papilloma virus vaccine) and certain types of pneumonia and diarrhoea. Pneumonia and diarrhoea are two of the biggest causes of deaths among children in the developing world and cervical cancer is a leading cause of death for women in Africa. Gavi will also have an important role to play if effective vaccines are produced against malaria and ebola. During 2016-2020, Gavi will in particular target reaching those in hard to reach areas in its target countries. Gavi also works with manufacturers to reduce the cost of vaccines for countries. The UK investment through Gavi will immunise an additional 75 million children against diseases and save over 1.25 million lives Project budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised. The current stage of the project, consistent with the International Aid Transparency Initiatives (IATI) classifications. A project can have up to 8 sectors, which are displayed with percentage allocations that total up to 100%. They are consistent with the Development Assistance Committees (DAC) classifications. A comparison of forecast spend and the total amount of money spent on the project to date. Some budgets may not be shown if projects are in an active procurement phase.

Sector Health & Medical

Contact Details

Company Name Global Alliance for Vaccines and Immunization
Address 1776 I (Eye) Street, NW Suite 600 Washington DC 20006 USA Tel: +1 202 478 1050 Fax: +1 202 478 1060 info@gavi.org
Web Site https://devtracker.dfid.gov.uk/projects/GB-1-204240

Filter Projects

Top